Northwire Canada EditionWednesday, July 29, 2026
Northwire
MTS 0.130 +0.0% PPX 0.210 +0.0% MCI 0.165 +0.0% ICON 0.030 −33.3% ACS 0.070 +0.0% EMPR 0.860 +2.4% CYG 0.140 +0.0% IZN 0.080 +33.3% XXIX 0.110 +0.0% MERG 0.815 −4.1% LEGY 0.910 +3.4% GTWO 9.28 −2.6% CDA 0.900 +1.1% AUMB 0.580 +0.0% BOL 0.075 +15.4% ABRA 13.68 −5.1% MTS 0.130 +0.0% PPX 0.210 +0.0% MCI 0.165 +0.0% ICON 0.030 −33.3% ACS 0.070 +0.0% EMPR 0.860 +2.4% CYG 0.140 +0.0% IZN 0.080 +33.3% XXIX 0.110 +0.0% MERG 0.815 −4.1% LEGY 0.910 +3.4% GTWO 9.28 −2.6% CDA 0.900 +1.1% AUMB 0.580 +0.0% BOL 0.075 +15.4% ABRA 13.68 −5.1%
Financings

Tocvan closes $10-million bought deal offering

TOC · Price

Executive Summary

  • Tocvan Ventures Corp. has closed a bought deal private placement raising $10,005,000 in gross proceeds, with Stifel Canada acting as sole underwriter and bookrunner.
  • The offering consisted of 10,005,000 units priced at $1.00 per unit, including the full exercise of the underwriter's 5% overallotment option.
  • Net proceeds are designated for advancing the company's gold projects in Sonora, Mexico, and for general working capital.

Key Details

  • Gross Proceeds: $10,005,000.
  • Units Issued: 10,005,000 units.
  • Price Per Unit: $1.00.
  • Underwriter: Stifel Canada (sole underwriter and bookrunner).
  • Overallotment: The underwriter exercised the full 5% overallotment option.
  • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
  • Warrant Terms:
    • Each warrant is exercisable for one additional common share.
    • Exercise Price: $1.40 per warrant share.
    • Term: 36 months following the closing date.
  • Underwriter Compensation:
    • Cash Commission: 7.0% of gross proceeds.
    • Compensation Warrants: 7.0% of the number of units sold.
    • Compensation Warrant Terms: Entitles holder to acquire a common share at the issue price ($1.00) for a period of 24 months from the date of issue.
  • Use of Proceeds: Advancing gold projects in Sonora, Mexico, and general working capital.
  • Regulatory Exemptions:
    • Canada: Offered pursuant to the listed issuer financing exemption under National Instrument 45-106 (Part 5A) and Coordinated Blanket Order 45-935. No statutory hold period applies.
    • United States: Offered via private placement exemptions from the U.S. Securities Act of 1933.
  • Related-Party Transactions:
    • Participation by Christopher Gordon (officer) and Anna Ladd-Kruger (director) was treated as a related-party transaction under Multilateral Instrument 61-101.
    • The company was exempt from obtaining a formal valuation or minority shareholder approval for insider participation.
Read the original news release →

More from Tocvan Ventures Corp